ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Update

ReShape Lifesciences Inc. (NASDAQ:RSLS) saw a large growth in short interest in February. As of February 15th, there was short interest totalling 82,800 shares, a growth of 266.4% from the January 31st total of 22,600 shares. Based on an average daily trading volume, of 930,400 shares, the short-interest ratio is currently 0.1 days. Currently, 62.6% of the shares of the stock are short sold.

ReShape Lifesciences Price Performance

ReShape Lifesciences stock opened at $1.03 on Friday. ReShape Lifesciences has a 52 week low of $0.98 and a 52 week high of $29.00. The stock has a fifty day moving average of $3.54 and a 200-day moving average of $5.52.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.